Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx

Share this content:
Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx
Intraoperative Methadone Cuts Post-Op Opioid Use in Spine Sx

MONDAY, May 1, 2017 (HealthDay News) -- For patients undergoing posterior spinal fusion surgery, intraoperative methadone administration is associated with reduced postoperative opioid requirements, according to a study published in the May issue of Anesthesiology.

Glenn S. Murphy, M.D., from the University of Chicago Pritzker School of Medicine in Evanston, Illinois, and colleagues conducted a parallel-group randomized trial to examine the effect of methadone on postoperative analgesic requirements, pain scores, and patient satisfaction after complex spine surgery. One hundred twenty patients undergoing posterior spinal fusion surgery were randomly allocated to receive methadone 0.2 mg/kg at the start of surgery or hydromorphone 2 mg at surgical closure.

Data were analyzed for 115 patients. The researchers found that median hydromorphone use was reduced in the methadone group on postoperative days one (4.56 versus 9.9 mg), two (0.6 versus 3.15 mg), and three (0 versus 0.4 mg). At 21 of 27 assessments, the methadone group had lower pain scores at rest, with movement, and with coughing. The methadone group had higher overall satisfaction with pain management until the morning of postoperative day three compared with the hydromorphone group.

"Intraoperative methadone administration reduced postoperative opioid requirements, decreased pain scores, and improved patient satisfaction with pain management," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Cost-Effectiveness of PCSK9 Inhibitors Called Into Question

Researchers say price would have to be between $4,000 and $5,000 per year to be cost-effective

Vitamin B6, B12 Supplements May Up Risk of Lung Cancer in Men

Vitamin B6, B12 Supplements May Up Risk of ...

Increased odds only seemed to affect men or male smokers

Tablet Use Encourages Patients to Explore Diabetes Risk

Tablet Use Encourages Patients to Explore Diabetes Risk

Replacing magazines with tablets can help patients learn about diabetes risk, take preventive action

is free, fast, and customized just for you!

Already a member?

Sign In Now »